XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment
Beginning balance (in shares) at Dec. 26, 2021     109,345,697      
Beginning balance at Dec. 26, 2021 $ 653,117 $ (4,944) $ 109 $ 1,129,224 $ (476,216) $ (4,944)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (141,183)       (141,183)  
Exercise of stock options (in shares) 819,454   819,454      
Exercise of stock options $ 3,978   $ 2 3,976    
Issuance of common stock related to restricted shares (in shares)     587,629      
Stock-based compensation expense 62,973     62,973    
Ending balance (in shares) at Sep. 25, 2022     110,752,780      
Ending balance at Sep. 25, 2022 573,941   $ 111 1,196,173 (622,343)  
Beginning balance (in shares) at Jun. 26, 2022     109,963,357      
Beginning balance at Jun. 26, 2022 606,316   $ 110 1,177,522 (571,316)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (51,027)       (51,027)  
Exercise of stock options (in shares)     258,844      
Exercise of stock options 1,051   $ 1 1,050    
Issuance of common stock related to restricted shares (in shares)     530,579      
Stock-based compensation expense 17,601     17,601    
Ending balance (in shares) at Sep. 25, 2022     110,752,780      
Ending balance at Sep. 25, 2022 573,941   $ 111 1,196,173 (622,343)  
Beginning balance (in shares) at Dec. 25, 2022     111,132,993      
Beginning balance at Dec. 25, 2022 541,226   $ 111 1,212,716 (671,601)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (85,970)       (85,970)  
Exercise of stock options (in shares) 888,309   888,309      
Exercise of stock options $ 5,111   $ 1 5,110    
Issuance of common stock related to restricted shares (in shares)     407,139      
Shares repurchased for employee tax withholding     (6,894)      
Shares repurchased for employee tax withholding (166)     (166)    
Stock-based compensation expense 40,133     40,133    
Ending balance (in shares) at Sep. 24, 2023     112,421,547      
Ending balance at Sep. 24, 2023 500,334   $ 112 1,257,793 (757,571)  
Beginning balance (in shares) at Jun. 25, 2023     111,946,454      
Beginning balance at Jun. 25, 2023 511,324   $ 112 1,243,728 (732,516)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (25,055)       (25,055)  
Exercise of stock options (in shares)     367,067      
Exercise of stock options 2,601     2,601    
Issuance of common stock related to restricted shares (in shares)     108,361      
Shares repurchased for employee tax withholding     (335)      
Shares repurchased for employee tax withholding (2)     (2)    
Stock-based compensation expense 11,466     11,466    
Ending balance (in shares) at Sep. 24, 2023     112,421,547      
Ending balance at Sep. 24, 2023 $ 500,334   $ 112 $ 1,257,793 $ (757,571)